Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus

American Journal of Medicine

Volumn 106, Issue 1, 1999, Pages 50-58

  Laederach Hofmann, Kurt ^a,b   Weidmann, Peter ^a   Ferrari, Paolo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; SODIUM;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPOVOLEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

EID: 0033018195     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00367-2     Document Type: Article

References (51)

1. Caviezel F., Picotti G., Margonato G., et al. Plasma adrenaline and noradrenaline concentrations in diabetic patients with and without autonomic neuropathy at rest and during sympathetic stimulation. Diabetologia. 23:1982;19-23.
2. Paolisso G., Cennamo G., Marfella R., et al. Exaggerated orthostatic hypotension at first sign of diabetic autonomic neuropathy in the elderly. Arch Gerontol Geriatr. 9:1989;107-113.
3. Purewal T., Watkins P. Postural hypotension in diabetic autonomic neuropathy a review . Diab Med. 12:1995;192-200.
4. Laederach-Hofmann K, Mussgay L, Winter A, Klinkenberg N, Rüddel H. Early autonomic dysfunction in patients with diabetes mellitus assessed by spectral analysis of heart rate and blood pressure variability. Clin Physiol 1998; in press.
5. Olshan A., O'Connor D., Cohen I., Mital J., Stone R. Baroreflex dysfunction in patients with adult-onset diabetes and hypertension. Am J Med. 74:1983;233-242.
6. Weidmann P., Ferrari P., Shaw S. Renin in diabetes mellitus. Robertson J., Nicholls M. The Renin Angiotensin System. 1993;75.1-75.26 Gower Medical Publishing, London.
7. Weidmann P. Die orthostatische Hypotonie. Schweiz Med Wochenschr. 114:1984;246-260.
8. Sato K., Kimura T., Ota K., et al. Changes in plasma vasopressin levels and cardiovascular function due to postural changes in diabetic neuropathy. Tohku J Exp Med. 177:1995;49-60.
9. Meier A., Gübelin U., Weidmann P., et al. Age-related profile of cardiovascular reactivity to norepinephrine and angiotensin II in normal and hypertensive man. Klin Wochenschr. 58:1980;1183-1188.
10. Saad C., Ribeiro A., Zanella M., Mulinari M., Gavras I., Gavras H. The role of vasopressin in blood pressure maintenance in diabetic orthostatic hypotension. Hypertension. 11:1988;I217-I221.
11. Weidmann P. Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertension. Clin Exp Hypertens. A11:(suppl 1):1989;257-273.
12. Weidmann P., Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabet Care. 14:1991;220-232.
13. De Châtel R., Weidmann P., Flammer J., et al. Sodium, renin, aldosterone, catecholamines and blood pressure in diabetes mellitus. Kidney Int. 12:1977;412-421.
14. Weidmann P., Beretta-Piccoli C., Trost B. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension. 7:(suppl II):1985;33-42.
15. Weidmann P., Reinhart R., Maxwell M., et al. Syndrome of hyporeninemic hypoaldosteronism and hyperkalemia in renal disease. J Clin Endocrinol Metab. 36:1973;965-977.
16. DiBona G. Neurogenic regulation on renal tubular sodium reabsorption. Am J Physiol. 233:1977;F73-F77.
17. Campbell I., Ewing D., Clarke B. Therapeutic experience with fludrocortisone in diabetic postural hypotension. BMJ. 1:1976;872-874.
18. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology. 46:1996;1470.
19. Goldberg L. Current therapy of hypertension a pharmacologic approach . Am J Med. 58:1975;489-494.
20. Chaudhuri K., Maule S., Thomaides T., Pavitt D., Mathias C. Alcohol ingestion lowers supine blood pressure, causes splachnic vasodilatation and worsens postural hypotension in primary autonomic failure. J Neurol. 241:1994;145-152.
21. Bertler A., Carlsson A., Rosengren E. A method for the fluorometric determination of adrenaline and noradrenaline in tissues. Acta Physiol Scand. 44:1958;273-292.
22. Weidmann P., Beretta-Piccoli C., Ziegler W.H., Keusch G., Glück Z., Reubi F.C. Age versus urinary sodium for judging renin, aldosterone and catecholamine levels studies in normal subjects and patients with essential hypertension . Kidney Int. 14:1978;619-628.
23. Weidmann P., Beretta-Piccoli C., Steffen F., Blumberg A., Reubi F. Hypertension in terminal renal failure. Kidney Int. 9:1976;294-301.
24. Beretta-Piccoli C., Weidmann P. Body sodium-blood volume state in nonazotemic diabetes mellitus. Min Electrol Metab. 7:1982;36-47.
25. Sealey J., Gertan-Banes J., Laragh J. The renin system variations in man measured by radioimmunoassay or bioassay . Kidney Int. 1:1972;240-253.
26. DaPrada M., Zūrcher G. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 19:1976;1161-1174.
27. Beretta-Piccoli C., Weidmann P. Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus. Am J Med. 71:1981;829-835.
28. Ewing D. Cardiovascular reflexes and autonomic neuropathy. Clin Sci. 55:1978;321-327.
29. O'Brien I., O'Hare J., Lewin I., Corrall R. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus a controlled study based on heart rate variability . Q J Med. 61:1986;975-987.
30. Neumann C., Schmid H. The relationship between the degree of cardiovascular autonomic dysfunction and symptoms of neuropathy and other complications of diabetes mellitus. Braz J Med Biol Res. 28:1995;751-757.
31. Glück Z., Boll H., Weidmann P., Flammer J., Ziegler W. Evaluation of autonomic neuropathy in diabetes mellitus. Comparison of clinical, functional and biochemical parameters. Klin Wochenschr. 57:1979;457-466.
32. Gautschy B., Weidmann P., Gnädinger M. Autonomic unction tests as related to age and gender in normal man. Klin Wochenschr. 64:1986;499-505.
33. Malpas S., Maling T. Heart-rate variability and cardiac autonomic function in diabetes. Diabetes. 39:1990;1177-1181.
34. Weidmann P., Böhlen L., DeCourten M. Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J. 125:1993;1498-1513.
35. Knox F., Mertz J., Burnett J., Haramati A. Role of hydrostatic and oncotic pressures in renal sodium reabsorption. Circ Res. 52:1983;491-500.
36. Parving H. Microvascular permeability to plasma protein in hypertension and diabetes mellitus in man - on the pathogenesis of hypertension and diabetic microangiopathy. Dan Med Bull. 22:1975;217-233.
37. Valensi P., Attali J., Behar A., Sebaoun J. Isotopic test of capillary permeability to albumin in diabetic patients effects of hypertension, microangiopathy and duration of diabetes . Metabolism. 36:1987;834-839.
38. Fujita T., Sato Y., Ando K. Role of sympathetic nerve activity and natriuresis in the antihypertensive actions of potassium in NaCl hypertension. Jpn Circ J. 47:1983;1227-1231.
39. Weidmann P., Hirsch D., Beretta-Piccoli C., Ziegler W., Reubi F. Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med. 62:1977;209-218.
40. Purewal T., Goss D., Zanone M., Edmonds M., Watkins P. The splachnic circulation and postural hypotension in diabetic autonomic neuropathy. Diabet Med. 12:1995;513-522.
41. Cryer P. Disorder of sympathetic neural function in human diabetes mellitus hypoadrenergic and hyperadrenergic postural hypotension . Metabolism. 29:(suppl 1):1980;1186-1189.
42. Johnson P. Thickening of the human dorsal root ganglion perineurial cell basement membrane in diabetes mellitus. Muscle Nerve. 6:1983;561-565.
43. Tsujimura T., Nunotani H., Fushimi H., Inoue T. Morphological changes in autonomic ganglionic cells of the heart in diabetic patients. Diabet Res Clin Pract. 2:1986;133-137.
44. Kjeldsen S., Eide I., Christensen C., Westheim A., Müller O. Renal contribution to plasma catecholamines - effect of age. Scand J Clin Lab Invest. 42:1982;461-466.
45. Link L., Weidmann P., Probst P., Futterlieb A. Renal handling of norepinephrine and epinephrine in the pig. Pflugers Arch. 405:1985;66-69.
46. Eisenhofer G., Esler M., Cox, et al. Differences in the neuronal removal of circulating epinephrine and norepinephrine. J Clin Endocrinol Metab. 70:1990;1710-1720.
47. Ferrari P., Weidmann P., Shaw S., et al. Altered insulin sensitivity, hyperinsulinemia and dyslipidemia in hypertension-prone humans. Am J Med. 91:1991;589-596.
48. Zander E., Schulz B., Heinke P., Grimmberger E., Zander G., Gottschling H. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic neuropathy. Diabet Care. 12:1989;259-264.
49. Okada S., Ishii K., Hamada H., et al. Is there a correlation between cardiac sympathetic neuropathy or diabetic somatic neuropathy and glycosylated hemoglobin or blood pressure in patients with non-insulin dependent diabetes mellitus? J Int Med Res. 23:1995;467-472.
50. Christlieb A., Janka H., Kraus B., et al. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 25:1976;268-274.
51. Drury P., Smith G., Ferriss J. Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia. 27:1984;174-179.